Disclosure Of Fair Value Measurement [Text Block]

Biocartis Group NV - Filing #3122958

Concept As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
114,277,000 EUR
142,480,000 EUR
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
30,284,000 EUR
5,843,000 EUR
631,722,000 EUR
7,502,000 EUR
443,363,000 EUR
220,302,000 EUR
30,284,000 EUR
526,405,000 EUR
33,897,000 EUR
5,572,000 EUR
33,897,000 EUR
711,874,000 EUR
6,862,000 EUR
220,657,000 EUR
455,343,000 EUR
36,824,000 EUR
220,657,000 EUR
5,153,000 EUR
711,874,000 EUR
6,102,000 EUR
36,824,000 EUR
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.